We rank companies based on fund manager, research analyst and news sentiment
ZYXI stock icon

Zynex
ZYXI

$12.07
0.66%
 

About: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Employees: 1,101

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

26% more capital invested

Capital invested by funds: $82.1M [Q3] → $104M (+$21.5M) [Q4]

0.5% less ownership

Funds ownership: 28.55% [Q3] → 28.05% (-0.5%) [Q4]

9% less funds holding

Funds holding: 120 [Q3] → 109 (-11) [Q4]

13% less call options, than puts

Call options by funds: $675K | Put options by funds: $772K

34% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 32

44% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 43

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$15
24%
upside
Avg. target
$18
49%
upside
High target
$21
74%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
RBC Capital
Shagun Singh
24%upside
$15
Outperform
Maintained
1 Mar 2024
HC Wainwright & Co.
Yi Chen
74%upside
$21
Buy
Maintained
1 Mar 2024

Financial journalist opinion